T2 Biosystems (TTOO) Competitors $0.15 +0.02 (+14.53%) As of 01:43 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TTOO vs. PAVM, ICU, BTCY, CODX, ALUR, SSKN, PSTV, POAI, NURO, and INBSShould you be buying T2 Biosystems stock or one of its competitors? The main competitors of T2 Biosystems include PAVmed (PAVM), SeaStar Medical (ICU), Biotricity (BTCY), Co-Diagnostics (CODX), Allurion Technologies (ALUR), STRATA Skin Sciences (SSKN), Plus Therapeutics (PSTV), Predictive Oncology (POAI), NeuroMetrix (NURO), and Intelligent Bio Solutions (INBS). These companies are all part of the "medical equipment" industry. T2 Biosystems vs. PAVmed SeaStar Medical Biotricity Co-Diagnostics Allurion Technologies STRATA Skin Sciences Plus Therapeutics Predictive Oncology NeuroMetrix Intelligent Bio Solutions T2 Biosystems (NASDAQ:TTOO) and PAVmed (NASDAQ:PAVM) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, risk, valuation, institutional ownership, analyst recommendations, earnings and community ranking. Is TTOO or PAVM more profitable? PAVmed has a net margin of 602.97% compared to T2 Biosystems' net margin of -563.16%. Company Net Margins Return on Equity Return on Assets T2 Biosystems-563.16% N/A -174.06% PAVmed 602.97%N/A -92.36% Do analysts rate TTOO or PAVM? T2 Biosystems currently has a consensus price target of $5.00, suggesting a potential upside of 3,743.20%. PAVmed has a consensus price target of $19.50, suggesting a potential upside of 2,820.91%. Given T2 Biosystems' higher probable upside, research analysts plainly believe T2 Biosystems is more favorable than PAVmed.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score T2 Biosystems 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00PAVmed 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 Does the media favor TTOO or PAVM? In the previous week, PAVmed had 1 more articles in the media than T2 Biosystems. MarketBeat recorded 2 mentions for PAVmed and 1 mentions for T2 Biosystems. PAVmed's average media sentiment score of 0.94 beat T2 Biosystems' score of 0.00 indicating that PAVmed is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment T2 Biosystems 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral PAVmed 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders have more ownership in TTOO or PAVM? 23.2% of T2 Biosystems shares are held by institutional investors. Comparatively, 19.9% of PAVmed shares are held by institutional investors. 0.0% of T2 Biosystems shares are held by company insiders. Comparatively, 11.3% of PAVmed shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has more volatility and risk, TTOO or PAVM? T2 Biosystems has a beta of 0.46, suggesting that its stock price is 54% less volatile than the S&P 500. Comparatively, PAVmed has a beta of 1.11, suggesting that its stock price is 11% more volatile than the S&P 500. Which has higher earnings & valuation, TTOO or PAVM? T2 Biosystems has higher revenue and earnings than PAVmed. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioT2 Biosystems$7.68M0.36-$50.08MN/AN/APAVmed$3.00M3.81-$64.18M-$2.25-0.30 Does the MarketBeat Community believe in TTOO or PAVM? T2 Biosystems received 202 more outperform votes than PAVmed when rated by MarketBeat users. However, 66.23% of users gave PAVmed an outperform vote while only 62.27% of users gave T2 Biosystems an outperform vote. CompanyUnderperformOutperformT2 BiosystemsOutperform Votes40662.27% Underperform Votes24637.73% PAVmedOutperform Votes20466.23% Underperform Votes10433.77% SummaryPAVmed beats T2 Biosystems on 11 of the 16 factors compared between the two stocks. Get T2 Biosystems News Delivered to You Automatically Sign up to receive the latest news and ratings for TTOO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TTOO vs. The Competition Export to ExcelMetricT2 BiosystemsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.14M$4.53B$5.45B$8.30BDividend YieldN/A47.07%5.44%4.20%P/E RatioN/A30.8725.7119.69Price / Sales0.4156.35411.89116.56Price / CashN/A51.0838.3134.62Price / Book-0.026.296.744.46Net Income-$50.08M$68.71M$3.23B$248.29M7 Day Performance-12.87%2.33%2.63%5.48%1 Year Performance-95.97%25.54%16.77%7.64% T2 Biosystems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TTOOT2 BiosystemsN/A$0.15+14.5%$5.00+3,255.7%-96.5%$3.14M$7.68M0.00180PAVMPAVmed4.616 of 5 stars$0.77-2.5%$19.50+2,432.5%-68.5%$13.16M$3.00M-0.1890Upcoming EarningsICUSeaStar Medical0.4458 of 5 stars$1.28-0.4%N/A-87.6%$12.55M$135,000.00-0.112Upcoming EarningsGap DownBTCYBiotricityN/A$0.49-1.6%N/A-58.4%$12.26M$12.06M-0.4640Gap UpCODXCo-Diagnostics4.4069 of 5 stars$0.35-4.3%$5.50+1,462.1%-69.4%$11.82M$3.92M-0.26100Earnings ReportGap UpALURAllurion Technologies2.8498 of 5 stars$2.36+1.1%$22.83+869.6%-95.1%$11.29M$32.11M-0.20501Upcoming EarningsNews CoverageGap DownSSKNSTRATA Skin Sciences3.2004 of 5 stars$2.68+1.9%$6.00+123.9%-34.4%$11.18M$33.56M-1.01120Upcoming EarningsNews CoverageGap UpPSTVPlus Therapeutics1.7326 of 5 stars$0.62-4.3%$11.50+1,753.9%-69.4%$10.55M$4.91M-0.2520Upcoming EarningsGap UpPOAIPredictive Oncology2.4464 of 5 stars$1.07-2.7%$3.00+180.4%-31.9%$9.56M$1.62M-0.3530Upcoming EarningsNews CoverageGap DownNURONeuroMetrix0.3913 of 5 stars$4.55+4.4%N/A+2.0%$9.37M$3.03M-0.9920High Trading VolumeINBSIntelligent Bio Solutions0.3325 of 5 stars$1.28-5.9%N/A-48.3%$8.72M$3.03M0.0010Upcoming EarningsGap Down Related Companies and Tools Related Companies PAVmed Competitors SeaStar Medical Competitors Biotricity Competitors Co-Diagnostics Competitors Allurion Technologies Competitors STRATA Skin Sciences Competitors Plus Therapeutics Competitors Predictive Oncology Competitors NeuroMetrix Competitors Intelligent Bio Solutions Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TTOO) was last updated on 5/12/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredVanishing BenefitsWhat would you do if your next Social Security check simply never arrived? If you called and the line was d...Investors Alley | SponsoredThe Man I Turn to In Times Like ThisA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredConfidential Economic AdvisoryI've hesitated for months to record this video. The very act of sharing these details makes me deeply uncom...InvestorPlace | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredThis picture could hold the secret to the market's next move.A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding T2 Biosystems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share T2 Biosystems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TTOO Stock Free TTOO Stock Alerts